US trends in vagal nerve stimulator implantation among patients with refractory epilepsy

Takeaway

  • Black patients with refractory epilepsy are almost 50% less likely than non-Hispanic white patients to receive vagal nerve stimulator (VNS) implants.

Why this matters

  • Use of VNS is an effective treatment option for patients with refractory epilepsy, and therefore eradicating racial disparity is essential to improve quality epilepsy care.